Drug Profile


Alternative Names: Girodazole; Girolline; NSC 627434; RP 49532; RP 49532A

Latest Information Update: 21 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aventis
  • Class Small molecules
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 20 Jan 2017 Discontinued - Phase-I for Cancer in France (IV)
  • 20 Oct 1999 Preclinical data have been added to the pharmacodynamics section
  • 14 Mar 1995 Suspended-I for Cancer in France (Infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top